Amy VandenBerg

18PUBLICATIONS
31CO-AUTHORS
PharmacogenomicsChiropracticClinical pharmacology and therapeuticsPredictive and prognostic markersToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 20, 2024
Clinical pearls for the management of duloxetine patients with medical comorbidities.

Megan O'Connell, Amy VandenBerg

|Jun 19, 2023
Loxapine in the Treatment of Manic and Psychotic Symptoms in an Individual Intolerant to Multiple Mood-Stabilizing and Antipsychotic Medications.

David S Im, Marina Capitanov, Amy M VandenBerg

|Nov 21, 2022
An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use.

Amy M VandenBerg

|Jul 08, 2022
Identifying olanzapine induced liver injury in the setting of acute hepatitis C: A case report.

Andrea Brelje, Bailey Fay, Scott Mariouw

|Jul 28, 2021
Loxapine in patient with clozapine-resistant psychosis.

Jennifer Erley, Sarah Goldsborough, Amy VandenBerg

|May 24, 2021
Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action.

Madison N Irwin, Amy VandenBerg

Pageof 3

Frequent Collaborators

4 joint publications

Erica A K Davis

2 joint publications

Jessica Broadway

2 joint publications

Megan O'Connell

2 joint publications

Sarah Goldsborough